Serial Number 97839309
Registration 7352095
700

Registration Progress

Application Filed
Mar 14, 2023
Under Examination
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Apr 9, 2024

Trademark Image

Basic Information

Serial Number
97839309
Registration Number
7352095
Filing Date
March 14, 2023
Registration Date
April 9, 2024
Published for Opposition
January 23, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 9, 2024
Registration
Registered
Classes
001 005 040 042
+1 more

Rights Holder

BioSpring Gesellschaft für Biotechnologie GmbH

16
Address
Alt-Fechenheim 34
Frankfurt 60386
DE

Ownership History

BioSpring Gesellschaft für Biotechnologie GmbH

Original Applicant
16
Frankfurt DE

BioSpring Gesellschaft für Biotechnologie GmbH

Owner at Publication
16
Frankfurt DE

BioSpring Gesellschaft für Biotechnologie GmbH

Original Registrant
16
Frankfurt DE

Legal Representation

Attorney
Julie A. Katz

USPTO Deadlines

Next Deadline
1525 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240409)
Due Date
April 09, 2030
Grace Period Ends
October 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
May 21, 2025 PRA7 O REGISTERED - SEC. 7 REQUEST ABANDONED Loading...
Oct 28, 2024 PRAM O POST REGISTRATION ACTION MAILED - SEC. 7 Loading...
Oct 27, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 12, 2024 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Apr 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 15, 2023 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Dec 14, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 14, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 14, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 14, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 14, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 14, 2023 IUAA P USE AMENDMENT ACCEPTED Loading...
Dec 11, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 25, 2023 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Aug 25, 2023 IUAF S USE AMENDMENT FILED Loading...
Aug 24, 2023 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Apr 5, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 17, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
oligonucleotides for use in the manufacture of pharmaceuticals; oligopeptides for industrial use; peptide substrates for scientific use; peptides for use in industry and science; peptides for use in research and the manufacture of reagents, diagnostic reagents for science and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; phosphoproteins; proteins for use in industry and science; reagents for research purposes; reagents for scientific use; nucleic acid for diagnostic research; nucleic acid for diagnostic manufacturing
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017
Class 005
nucleic acid reagents, agents, preparations and substances for medical purposes; nucleic acid sequences for medical and veterinary use; oligonucleotides for diagnostic purposes; oligonucleotides for medical diagnostic purposes; oligonucleotides for medical use; oligonucleotides for pharmaceutical purposes; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations against neurological diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; pharmaceutical preparations for wound healing; reagents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; tumor suppressing agents
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017
Class 040
biochemical contract manufacturing services; chemical synthesis services, namely, custom synthesis of chemicals for others; custom manufacture of biopharmaceuticals; custom manufacture of pharmaceuticals; custom manufacturing of oligonucleotides; custom modification of antibody; custom modification of protein; development services, namely, design and development of manufacturing processes for others in the field of oligonucleotides; manufacturing, namely, contract manufacturing in the field of oligonucleotides; processing of biopharmaceutical materials for others; processing of chemical reagents; processing of chemicals; processing of medicinal materials; processing of oligonucleotides; processing of peptides; processing of proteins; technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017
Class 042
scientific analysis services for the identification and physical characterization of chemical molecules; scientific and technical services, namely, scientific analysis of industrial installations; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations; scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific development services in the field of biochemistry; scientific laboratory services; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and development services in the field of pharmaceuticals; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific research services, namely, nucleic acid analysis; scientific research services, namely, oligonucleotide analysis; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bio-organics; scientific study and research services in the field of industrial safety
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017
Class 044
nucleic acid analysis for medical diagnostic and treatment purposes; oligonucleotide analysis for medical diagnostic and treatment purposes
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017

Additional Information

Design Mark
The mark consists of a helix in a circle with a line around the middle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 040 042 044